These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10669267)

  • 1. Effects of melagatran, an inhibitor of thrombin, on fibrin deposits, haemodynamics, and platelet count in endotoxaemic pigs.
    Eriksson M; Saldeen T; Mattsson C; Larsson A
    Acta Anaesthesiol Scand; 2000 Jan; 44(1):24-31. PubMed ID: 10669267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melagatran, a low molecular weight thrombin inhibitor, counteracts endotoxin-induced haemodynamic and renal dysfunctions in the pig.
    Eriksson M; Larsson A; Saldeen T; Mattsson C
    Thromb Haemost; 1998 Dec; 80(6):1022-6. PubMed ID: 9869178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of melagatran, a novel direct thrombin inhibitor, during experimental septic shock.
    Eriksson M; Basu S; Larsson A; Mattsson C; Eriksson O; Kiiski R; Nordgren A
    Expert Opin Investig Drugs; 2000 May; 9(5):1129-37. PubMed ID: 11060733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of thrombin inhibition with melagatran on renal hemodynamics and function and liver integrity during early endotoxemia.
    Nitescu N; Grimberg E; Ricksten SE; Marcussen N; Nordlinder H; Guron G
    Am J Physiol Regul Integr Comp Physiol; 2007 Mar; 292(3):R1117-24. PubMed ID: 17068159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melagatran attenuates fibrin and platelet deposition in a porcine coronary artery over-stretch injury model.
    Scherstén F; Wahlund G; Björnheden T; Carlsson S; Mattsson C; Grip L
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):235-41. PubMed ID: 12695745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of pre-treatment with vitamin A on cardiac and pulmonary functions in endotoxaemic pigs.
    Eriksson M; Lundkvist K; Drott P; Saldeen T; Eriksson O
    Acta Anaesthesiol Scand; 1996 May; 40(5):538-48. PubMed ID: 8792882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin A exerts potential therapeutic effects in the endotoxaemic pig.
    Eriksson M; Lundkvist K; Larsson A; Nelson D; Saldeen T; Drott P; Eriksson O
    Acta Anaesthesiol Scand; 1997 Aug; 41(7):824-9. PubMed ID: 9265923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early endotoxin-mediated haemostatic and inflammatory responses in the clopidogrel-treated pig.
    Lipcsey M; Larsson A; Olovsson M; Sjölin J; Eriksson MB
    Platelets; 2005 Nov; 16(7):408-14. PubMed ID: 16236602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of activated prothrombin complex concentrate or recombinant factor VIIa on the bleeding time and thrombus formation during anticoagulation with a direct thrombin inhibitor.
    Elg M; Carlsson S; Gustafsson D
    Thromb Res; 2001 Feb; 101(3):145-57. PubMed ID: 11228338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No influence of mild-to-moderate hepatic impairment on the pharmacokinetics and pharmacodynamics of ximelagatran, an oral direct thrombin inhibitor.
    Wåhlander K; Eriksson-Lepkowska M; Frison L; Fager G; Eriksson UG
    Clin Pharmacokinet; 2003; 42(8):755-64. PubMed ID: 12846596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of melagatran, a new low-molecular-weight thrombin inhibitor, on thrombin and fibrinolytic enzymes.
    Gustafsson D; Antonsson T; Bylund R; Eriksson U; Gyzander E; Nilsson I; Elg M; Mattsson C; Deinum J; Pehrsson S; Karlsson O; Nilsson A; Sörensen H
    Thromb Haemost; 1998 Jan; 79(1):110-8. PubMed ID: 9459334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melagatran, an oral active-site inhibitor of thrombin, prevents or delays formation of electrically induced occlusive thrombus in the canine coronary artery.
    Mehta JL; Chen L; Nichols WW; Mattsson C; Gustafsson D; Saldeen TG
    J Cardiovasc Pharmacol; 1998 Mar; 31(3):345-51. PubMed ID: 9514177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combination of a thrombin inhibitor and dexamethasone prevents the development of experimental disseminated intravascular coagulation in rats.
    Elg M; Gustafsson D
    Thromb Res; 2006; 117(4):429-37. PubMed ID: 15869787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The direct thrombin inhibitor melagatran counteracts endotoxin-induced endothelial leukocyte adherence and microvascular leakage in the rat mesentery. Rationale for the treatment of inflammatory disorders beyond sepsis?
    Leithäuser B; Fassbender M; Eickhoff M; Elg M; Eichner G; Matthias FR
    Clin Hemorheol Microcirc; 2007; 36(4):277-89. PubMed ID: 17502698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: possible application of the thrombin inhibitor melagatran in clinical islet transplantation.
    Ozmen L; Ekdahl KN; Elgue G; Larsson R; Korsgren O; Nilsson B
    Diabetes; 2002 Jun; 51(6):1779-84. PubMed ID: 12031965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of recombinant factor VIIa on melagatran-induced inhibition of thrombin generation and platelet activation in healthy volunteers.
    Wolzt M; Levi M; Sarich TC; Boström SL; Eriksson UG; Eriksson-Lepkowska M; Svensson M; Weitz JI; Elg M; Wåhlander K
    Thromb Haemost; 2004 Jun; 91(6):1090-6. PubMed ID: 15175794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ximelagatran, an oral direct thrombin inhibitor, has a low potential for cytochrome P450-mediated drug-drug interactions.
    Bredberg E; Andersson TB; Frison L; Thuresson A; Johansson S; Eriksson-Lepkowska M; Larsson M; Eriksson UG
    Clin Pharmacokinet; 2003; 42(8):765-77. PubMed ID: 12846597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, are not influenced by acetylsalicylic acid.
    Fager G; Cullberg M; Eriksson-Lepkowska M; Frison L; Eriksson UG
    Eur J Clin Pharmacol; 2003 Aug; 59(4):283-9. PubMed ID: 12845508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endotoxaemic liver injury in a porcine model--relation to tumour necrosis factor-alpha release and survival.
    Eriksson M; Larsson A; Lundkvist K; Lööf L
    Scand J Infect Dis; 1998; 30(2):169-72. PubMed ID: 9730305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulant action of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, in umbilical cord and adult plasma: an in vitro examination.
    Koestenberger M; Gallistl S; Cvirn G; Baier K; Leschnik B; Muntean W
    Thromb Res; 2005; 115(1-2):135-42. PubMed ID: 15567465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.